Literature DB >> 24894398

Inhibition by all-trans-retinoic acid of transforming growth factor-β-induced collagen gel contraction mediated by human tenon fibroblasts.

Yang Liu1, Kazuhiro Kimura2, Tomoko Orita2, Shinichiro Teranishi2, Katsuyoshi Suzuki2, Koh-Hei Sonoda2.   

Abstract

PURPOSE: Excessive wound contraction can lead to scar formation in the conjunctiva. The effects of all-trans-retinoic acid (ATRA) on the contractility of human Tenon fibroblasts (HTFs) cultured in three-dimensional (3D) collagen gels were investigated.
METHODS: Human Tenon fibroblasts were cultured in 3D gels of type I collagen and in the absence or presence of TGF-β, ATRA, or various inhibitors. Collagen gel contraction was evaluated by measurement of gel diameter. Phosphorylation of various signaling molecules was examined by immunoblot analysis. The formation of actin stress fibers and focal adhesions was detected by laser confocal microscopy.
RESULTS: All-trans-retinoic acid inhibited TGF-β-induced collagen gel contraction mediated by HTFs in a concentration- and time-dependent manner. The TGF-β-induced phosphorylation of focal adhesion kinase (FAK) and formation of stress fibers and focal adhesions in HTFs were attenuated by ATRA. All-trans-retinoic acid also inhibited the TGF-β-induced phosphorylation of the mitogen-activated protein kinases (MAPKs) extracellular signal-regulated kinase (ERK), p38, and c-Jun NH2-terminal kinase (JNK) as well as that of c-Jun and Smad2/3. Furthermore, TGF-β-induced collagen gel contraction was blocked by inhibitors of ERK, p38, or JNK signaling.
CONCLUSIONS: All-trans-retinoic acid inhibited TGF-β-induced collagen gel contraction mediated by HTFs, most likely by attenuating the formation of actin stress fibers and focal adhesions as well as signaling by MAPKs, c-Jun, and Smads. All-trans-retinoic acid may therefore prove effective for inhibition of conjunctival scarring through attenuation of the contractility of Tenon fibroblasts. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  Tenon fibroblasts; all-trans-retinoic acid; transforming growth factor-β; wound healing

Mesh:

Substances:

Year:  2014        PMID: 24894398     DOI: 10.1167/iovs.13-13572

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  Attenuation of EMT in RPE cells and subretinal fibrosis by an RAR-γ agonist.

Authors:  Kazuhiro Kimura; Tomoko Orita; Yang Liu; Yang Yang; Kazuhiro Tokuda; Taishi Kurakazu; Takeshi Noda; Ryoji Yanai; Naoyuki Morishige; Atsunobu Takeda; Tatsuro Ishibashi; Koh-Hei Sonoda
Journal:  J Mol Med (Berl)       Date:  2015-05-08       Impact factor: 4.599

2.  Tranilast inhibits TGF-β-induced collagen gel contraction mediated by human corneal fibroblasts.

Authors:  Ye Liu; Xiao-Jing Zhao; Xiao-Shuo Zheng; Hui Zheng; Lei Liu; Ling-Bin Meng; Qin Li; Yang Liu
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779

3.  Triptolide inhibits TGF-β-induced matrix contraction and fibronectin production mediated by human Tenon fibroblasts.

Authors:  Yang Liu; Ping-Ping Liu; Lei Liu; Xiao-Shuo Zheng; Hui Zheng; Cheng-Cheng Yang; Ci-Ren Luobu; Ye Liu
Journal:  Int J Ophthalmol       Date:  2018-07-18       Impact factor: 1.779

4.  Inhibition by a retinoic acid receptor γ agonist of extracellular matrix remodeling mediated by human Tenon fibroblasts.

Authors:  Yang Liu; Kazuhiro Kimura; Tomoko Orita; Katsuyoshi Suzuki; Shinichiro Teranishi; Takuya Mori; Koh-Hei Sonoda
Journal:  Mol Vis       Date:  2015-12-31       Impact factor: 2.367

5.  Targeted killing of myofibroblasts by biosurfactant di-rhamnolipid suggests a therapy against scar formation.

Authors:  Chong Shen; Lifang Jiang; Huawei Shao; Chuangang You; Guoliang Zhang; Sitong Ding; Tingwei Bian; Chunmao Han; Qin Meng
Journal:  Sci Rep       Date:  2016-11-30       Impact factor: 4.379

6.  Inhibition of epithelial-mesenchymal transition in retinal pigment epithelial cells by a retinoic acid receptor-α agonist.

Authors:  Yuka Kobayashi; Kazuhiro Tokuda; Chiemi Yamashiro; Fumiaki Higashijima; Takuya Yoshimoto; Manami Ota; Tadahiko Ogata; Atsushige Ashimori; Makoto Hatano; Masaaki Kobayashi; Sho-Hei Uchi; Makiko Wakuta; Kazuhiro Kimura
Journal:  Sci Rep       Date:  2021-06-04       Impact factor: 4.379

7.  All-trans Retinoic Acids Synergistically and Beneficially Affect In Vitro Glaucomatous Trabecular Meshwork (TM) Models Using 2D and 3D Cell Cultures of Human TM Cells.

Authors:  Megumi Watanabe; Tatsuya Sato; Yuri Tsugeno; Megumi Higashide; Masato Furuhashi; Araya Umetsu; Soma Suzuki; Yosuke Ida; Fumihito Hikage; Hiroshi Ohguro
Journal:  Int J Mol Sci       Date:  2022-08-31       Impact factor: 6.208

8.  All Trans-Retinoic Acids Facilitate the Remodeling of 2D and 3D Cultured Human Conjunctival Fibroblasts.

Authors:  Yuri Tsugeno; Tatsuya Sato; Megumi Watanabe; Megumi Higashide; Masato Furuhashi; Araya Umetsu; Soma Suzuki; Yosuke Ida; Fumihito Hikage; Hiroshi Ohguro
Journal:  Bioengineering (Basel)       Date:  2022-09-11

9.  MEK inhibition prevents TGF‑β1‑induced myofibroblast transdifferentiation in human tenon fibroblasts.

Authors:  Jiamin Wen; Xianchai Lin; Wuyou Gao; Bo Qu; Yunlan Ling; Rongjiao Liu; Minbin Yu
Journal:  Mol Med Rep       Date:  2018-11-20       Impact factor: 2.952

10.  The Potential Role of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) in Glaucoma: A Review.

Authors:  Mingxuan Wang; Jia Li; Yajuan Zheng
Journal:  Med Sci Monit       Date:  2020-01-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.